AU2022902742A0 - Anti-CCR8 antibodies - Google Patents

Anti-CCR8 antibodies

Info

Publication number
AU2022902742A0
AU2022902742A0 AU2022902742A AU2022902742A AU2022902742A0 AU 2022902742 A0 AU2022902742 A0 AU 2022902742A0 AU 2022902742 A AU2022902742 A AU 2022902742A AU 2022902742 A AU2022902742 A AU 2022902742A AU 2022902742 A0 AU2022902742 A0 AU 2022902742A0
Authority
AU
Australia
Prior art keywords
ccr8 antibodies
ccr8
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2022902742A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monash University
Original Assignee
Monash University
Filing date
Publication date
Application filed by Monash University filed Critical Monash University
Publication of AU2022902742A0 publication Critical patent/AU2022902742A0/en
Priority to PCT/AU2023/050916 priority Critical patent/WO2024059909A1/en
Abandoned legal-status Critical Current

Links

AU2022902742A 2022-09-21 2022-09-21 Anti-CCR8 antibodies Abandoned AU2022902742A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2023/050916 WO2024059909A1 (en) 2022-09-21 2023-09-21 Anti-ccr8 antibodies

Publications (1)

Publication Number Publication Date
AU2022902742A0 true AU2022902742A0 (en) 2022-10-06

Family

ID=

Similar Documents

Publication Publication Date Title
EP3986936A4 (en) Anti-tigit antibodies
EP4144370A4 (en) Bispecific antibody
EP3986462A4 (en) Anti-tim-3 antibodies
EP3995582A4 (en) Anti-epha4 antibody
EP4165079A4 (en) Hiv-1 antibodies
EP3917965A4 (en) Novel anti-ifnar1 antibodies
EP4121110A4 (en) Anti-ceramide antibodies
EP4163301A4 (en) Humanized anti-gpc-1 antibody
EP4081539A4 (en) Novel anti-fgfr2b antibodies
EP4081547A4 (en) Novel anti-fgfr2b antibodies
EP4081546A4 (en) Novel anti-fgfr2b antibodies
EP4070816A4 (en) Anti-gdf15 antibody
AU2022902836A0 (en) SARS-CoV-2 antibodies
AU2022902742A0 (en) Anti-CCR8 antibodies
EP3980456A4 (en) Affinity-maturated anti-asic1a antibodies
AU2020904811A0 (en) SARS-CoV-2 antibodies
AU2020904813A0 (en) SARS-CoV-2 antibodies
AU2020903586A0 (en) Clec9A antibodies
AU2023901311A0 (en) Structurally constrained antibodies
AU2023900642A0 (en) Multifunctional antibodies
AU2022902552A0 (en) Multifunctional antibodies
AU2023903759A0 (en) Aminopeptidase antibodies
EP4146706A4 (en) Inhibiting anti-enpp1 antibodies
AU2023903890A0 (en) Novel radiolabelled antibodies
EP3917956A4 (en) Anti-fgf19 antibodies